- Neuroendocrine regulation and behavior
- Maternal and fetal healthcare
- Maternal and Perinatal Health Interventions
- Biomedical and Engineering Education
- Innovation Policy and R&D
- Entrepreneurship Studies and Influences
Brooke Army Medical Center
2024-2025
Joint Base San Antonio
2025
The prophylactic use of oxytocin after cesarean delivery has been shown to reduce maternal blood loss by 40 50%, yet there remains significant clinical deviation in how the medication is dosed. In January, 2021, Defense Health Agency issued Procedural Instruction 6025.35 entitled Guidance for Implementation Postpartum Hemorrhage Bundle. This directive established a set processes and procedures risk assessment treatment postpartum hemorrhage, including new standardized protocol vaginal...
<title>Abstract</title> Background The prophylactic use of oxytocin after fetal delivery has been shown to reduce maternal blood loss by 40–50%, yet there remains significant clinical deviation in how the medication is dosed. In January, 2021, Defense Health Agency (DHA) issued Procedural Instruction 6025.35 entitled Guidance for Implementation Postpartum Hemorrhage Bundle. This directive established a set processes and procedures risk assessment treatment postpartum hemorrhage (PPH),...